MGC Pharmaceuticals secure a European cannabis manufacturing license for a facility in Slovenia, whilst elsewhere, XHemplar plant up 25 acres of ‘cannabis light’ in Italy. Meanwhile, Genetically modified cannabis may be close to a breakthrough, and Prohibition Partners announce the release of The European Cannabis Report™ 3rd Edition.
Crop signs an agreement to cultivate over half a million square feet of ‘cannabis 'light’ in Italy, while elsewhere Maricann receives a letter of intent from Malta Enterprise, allowing them to move ahead with licensing. Meanwhile, Switzerland’s government proposes medical cannabis pilot programmes and the UK opposition calls for cannabis decriminalisation.
Aurora becomes the first licensed supplier to the Maltese medical cannabis industry, while Canopy CEO Bruce Linton suggests that future of cannabis may be as product, not as a commodity. Elsewhere, Luxembourg votes in favour of legalising medical cannabis, as Britain inches closer to a regulated medical market.
Parisians line up to buy low-THC ‘cannabis light’ in newly opened store, while German insurers release their first insights into the business of covering medical cannabis. Elswhere, UK border force confiscates ‘openly smuggled’ cannabis oil from Charlotte Caldwell, as she attempts to treat her severely epileptic son.
A new study finds that legalising cannabis could boost UK tax revenue by up to £3.5 billion per year, while the global drinks industry, suggests cannabis is its single biggest threat. Meanwhile, after weeks of raids, Denmark’s Freetown Christiania market finally concedes and stops selling cannabis. Also in the news is an early test suggesting that cannabis could effectively treat symptoms of Lyme disease.
GW Pharma makes a breakthrough with US Food and Drug Administration, while Aurora heavily expands it’s German market presence. Meanwhile, a new study finds that the majority of Britons would prefer a softer stance on cannabis, as the French Health Minister suggests medical cannabis could be on its way…
Maricaan Group closes the acquisition of Swiss company Haxxon, as Organigram sets up to acquire 25% of German company Alpha-Cannabis. Marches in Peru and Argentina demand new cannabis laws, while the British Medical Journal argues for legalised, regulated and taxed cannabis. Meanwhile, new studies suggest cannabis could treat anxiety, depression and PTSD.